Question to the Department of Health and Social Care:

To ask His Majesty's Government whether the ranking methodology for the proposed single national formulary will include (1) workforce productivity, (2) equitable patient access, and (3) quality of life outcomes.

The 10-Year Health Plan for England set out a commitment to move towards a Single National Formulary (SNF) for medicines within the next two years. The plan details that the SNF will include sequencing of products within clinical pathways based on clinical and cost effectiveness, overseen by a new formulary oversight board supported by the National Institute for Health and Care Excellence (NICE). NICE guidance will be used for the underpinning clinical and cost effectiveness evidence, including resource implications, to guide these decisions. The SNF will be a key enabler to support fair and equitable patient access to NICE-approved medicines across the country.

Work is already underway to deliver the SNF through a phased approach. We are already working closely and collaboratively with key stakeholders including NICE and the pharmaceutical industry and medical royal colleges, to develop and design the implementation of the SNF. We will continue to utilise local expertise to ensure the SNF is successfully implemented, and local system support, particularly from pharmacy and medicines formulary teams, will be essential to successful delivery of the SNF, which is why joint activity has already started early in the process.